Skip to main content
# Title Department Research Member Research Year
521 Pediatric Osteosarcoma of Extremities: a 15-year Experience from a Tertiary Care Cancer Center in Upper Egypt Department of Radiology Dr. Doaa Mohamed Fouad Mahmoud 2019
522 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2019
523 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2019
524 Prognostic Value of c-Myc Immunohistochemical Expression in Muscle Invasive Urothelial Carcinoma of the Urinary Bladder: A Retrospective Study Department of Pathology Amira Emad Mohamed Elwy 2019
525 Immunohistochemical study of folate receptor-α and mammalian
target of rapamycin in endometrial hyperplasia and
endometrioid endometrial carcinoma


Department of Radiotherapy and Nuclear medicine Dr. Asmaa elsayed abdelsalam /hasaballah 2019
526 Pediatric Osteosarcoma of Extremities: a 15-year Experience from a Tertiary Care Cancer Center in Upper Egypt Department of Radiology Dr. Hossam El-Din / Mostafa Kamel Mohamed 2019
527 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Department of Medical Oncology Nehal Adel Rayan Mohammed 2019
528 The Prognostic Implication of CD49d Expression by Flow Cytometry and Trisomy 12 Detection by Fluorescent in situ Hybridization in Chronic Lymphocytic Leukemia Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2019
529 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2019
530 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2019